Webinar: Findings from the UK’s independent review of science on nicotine vaping and risk. What they said and why.

See you there


July 05, 2023 at 8:30am - 9:15am






Courtney Carter-Smith Arifin Fii Maria Cotter Amy-lee Bruhn Mauricio Olmedo-Perez gabrielle stewart Hayley Pritchard Joy Davidson-Sheard Helen Marshall Grant Hocking Maria De Cort Hilary Genet Linda Lim Natalie Walker Koratika Tiban Skip Murray Vera Karataua Karen Petrie Jude Ball chelus Ramari Knowles Sophia Bloomfield Georgina Wellington Tau Moeke Isabel Foley Sally Thomas Rowan Manhire-Heath Greg Newton Tashina Katene Carmen Cunningham Mary Strang Mick Chan Julie Beckett Mitchell Jordan Richard Edwards Caitlin Pascoe tupu siafausa Dunya Wardak Tiana Bennett Lizzie Spence Karmin Erueti Teresa Doran Laura Johnstone Tom Broadhead Jacob Taiapa Emma Hindson Nicola Jackson Jane Liggins Martin Cullip

Leave your email address

Who's coming along
  • Courtney Carter-Smith Courtney is attending
  • Arifin Fii Arifin is attending
  • Maria Cotter Maria is attending
  • Amy-lee Bruhn Amy-lee is attending
  • Mauricio Olmedo-Perez Mauricio is attending
  • gabrielle stewart gabrielle is attending

Webinar: Findings from the UK’s independent review of science on nicotine vaping and risk. What they said and why.

ASH LogoNZ Drug Foundation Logo

ASH and the New Zealand Drug Foundation are pleased to host a breakfast webinar with Professor Ann McNeil and Dr Debbie Robson, lead authors of the Public Health England and Office for Health and Disparities review of vaping and health.

Professor Ann McNeilDr Debbie Ronson

Learn more about the speakers here. 

For the last decade the UK Office for Health and Disparities (formally Public Health England) has commissioned a series of independent systematic reviews on vaping in youth and adults. They are among the most widely cited sources to communicate relative and absolute risks of vaping, and have informed policy makers worldwide.

The latest report was published in late 2022 with a particular focus on vaping compared to smoking and non-smoking. This webinar will provide an overview of the latest report from the lead authors and explain how they came to the conclusions that vaping poses a small fraction of the risk of smoking, but is not risk free.

It will also draw on the authors’ learnings from 8 years of conducting reviews of evidence around vaping and risk, and recommendations to improve the quality of vaping research to inform policy makers and public health action.

The full report can be accessed here.

Who should attend?

This webinar is for anyone working in public health, addictions, smoking cessation, policy, NGOs, research, advocacy and government with an interest in smokefree, vaping and harm reduction.

This webinar will explain the latest science and the methods used to reach the Report’s conclusions. It will also provide insights into how the findings can be used, and encourage critical thinking about current and future vaping research.

The webinar will last 45 minutes with an opportunity to submit questions. All questions will be moderated for clarity, relevance and timekeeping.

Please note, you must register for this webinar. A link to the session will be provide to all registered attendees.